Androgen antagonists: Potential role in prostate cancer prevention

This publication has 20 references indexed in Scilit:

• Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5α-reductase
  The Journal of Steroid Biochemistry and Molecular Biology, 2000
• PROGRESSIVE OSTEOPOROSIS DURING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER
  Journal of Urology, 2000
• Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate Cancer
  New England Journal of Medicine, 1999
• PILOT EVALUATION OF VENLAFAXINE FOR THE TREATMENT OF HOT FLASHES IN MEN UNDERGOING ANDROGEN ABLATION THERAPY FOR PROSTATE CANCER
  Journal of Urology, 1999
• SELECTIVITY OF FINASTERIDE AS AN IN VIVO INHIBITOR OF 5 alpha-REDUCTASE ISOZYME ENZYMATIC ACTIVITY IN THE HUMAN PROSTATE
  Journal of Urology, 1999
• Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
  New England Journal of Medicine, 1997
• Randomised Study of Casodex 50 Mg Monotherapy vs Orchidectomy in the Treatment of Metastatic Prostate Cancer
  Scandinavian Journal of Urology and Nephrology, 1996
• Single-agent therapy with bicalutamide: A comparison with medical or surgical castration in the treatment of advanced prostate carcinoma
  Urology, 1995
• The Effect of Finasteride in Men with Benign Prostatic Hyperplasia
  New England Journal of Medicine, 1992
• Leuprolide versus Diethylstilbestrol for Metastatic Prostate Cancer
  New England Journal of Medicine, 1984